Reviva Pharmaceuticals Holdings (RVPH) Research & Development (2021 - 2026)
Reviva Pharmaceuticals Holdings' Research & Development was $1.39 million in Q2 2026, down 62.6% from $3.72 million a year earlier and down 2.8% from the prior quarter.
Powered by 
Analysis
Reviva Pharmaceuticals Holdings (RVPH) Research & Development (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Reviva Pharmaceuticals Holdings' Research & Development was $6.7 million through Jun 30, 2026, down 65.4% year-over-year; for FY2025, it was $11.71 million, down 48.9% from FY2024.
- Research & Development shows a five-year compound annual growth rate of 108.8% (FY2020 to FY2025).
- In earlier years, Research & Development was $22.91 million in FY2024 (-27.1%), $31.42 million in FY2023 (+37.4%), $22.87 million in FY2022 (+371.4%) and $4.85 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Research & Development since Q2 2021.
- Compared with a year earlier, Research & Development has declined for nine straight quarters, with an average decline of 49.0% over the last eight quarters.
- The best year-over-year quarter for Research & Development over five years was Q3 2022 (growth of 198.0%); the worst was Q3 2025 (a decline of 68.9%).
- Per Business Quant data, RVPH's Research & Development in the three quarters before Q2 2026 was $1.44 million (Q1 2026), $1.74 million (Q4 2025) and $2.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Reviva Pharmaceuticals Holdings | 4.46 Mn | -82.75 Mn | - | 1.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.20 Mn |
| Jun 30, 2026 | 1.39 Mn |
| Mar 31, 2026 | 1.44 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | 2.13 Mn |
| Jun 30, 2025 | 3.72 Mn |
| Mar 31, 2025 | 4.11 Mn |
| Dec 31, 2024 | 4.68 Mn |
| Sep 30, 2024 | 6.86 Mn |
| Jun 30, 2024 | 5.58 Mn |
| Mar 31, 2024 | 5.78 Mn |
| Dec 31, 2023 | 8.11 Mn |
| Sep 30, 2023 | 9.57 Mn |
| Jun 30, 2023 | 8.26 Mn |
| Mar 31, 2023 | 5.48 Mn |
| Dec 31, 2022 | 7.42 Mn |
| Sep 30, 2022 | 4.24 Mn |
| Jun 30, 2022 | 4.51 Mn |
| Mar 31, 2022 | 5.83 Mn |
| Dec 31, 2021 | 2.66 Mn |
API Access
Reviva Pharmaceuticals Holdings Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RVPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RVPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RVPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();